PIMOBENDAN powder

Pays: États-Unis

Langue: anglais

Source: NLM (National Library of Medicine)

Ingrédients actifs:

PIMOBENDAN (UNII: 34AP3BBP9T) (PIMOBENDAN - UNII:34AP3BBP9T)

Disponible depuis:

Boehringer Ingelheim Espana, SA

DCI (Dénomination commune internationale):

PIMOBENDAN

Composition:

PIMOBENDAN 1 mg in 100 L

Statut de autorisation:

Bulk Ingredient For Animal Drug Compounding

Résumé des caractéristiques du produit

PIMOBENDAN- PIMOBENDAN POWDER
BOEHRINGER INGELHEIM ESPANA, SA
----------
PIMOBENDAN
pimobendan powder
PRODUCT INFORMATION
PRODUCT T YPE
BULK INGREDIENT
ITE M CODE (SOURCE )
NDC:6 540 4-0 0 4
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
PIMO BENDAN (UNII: 34AP3BBP9 T) (PIMOBENDAN - UNII:34AP3BBP9 T)
PIMOBENDAN
1 mg in 10 0 L
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:6 540 4-0 0 4-9 9
10 0 L in 1 DRUM
0 2/17/20 16
Boehringer Ingelheim Espana, SA
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH
CITA TIO N
MARKE TING START
DATE
MARKE TING END
DATE
BULK INGREDIENT FOR ANIMAL DRUG
COMPOUNDING
0 2/17/20 16
LABELER -
Boehringer Ingelheim Espana, SA (460940841)
REGISTRANT -
Boehringer Ingelheim Espana, SA (460940841)
Revised: 2/2016